Immediate functional progression program in adolescent athletes with a spondylolysis.
Athlete
Bone stress injury
Low back pain
Youth
Journal
Physical therapy in sport : official journal of the Association of Chartered Physiotherapists in Sports Medicine
ISSN: 1873-1600
Titre abrégé: Phys Ther Sport
Pays: England
ID NLM: 100940513
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
12
04
2021
revised:
19
08
2021
accepted:
20
08
2021
pubmed:
7
9
2021
medline:
17
11
2021
entrez:
6
9
2021
Statut:
ppublish
Résumé
To assess the preliminary evidence for the efficacy and safety of an immediate functional progression program to treat adolescent athletes with an active spondylolysis. Prospective single-arm trial. Hospital-based sports medicine and physical therapy clinic. Twelve adolescent athletes (14.2 ± 2 years, 25% female) with an active spondylolysis. Clinical outcomes included time out of sport, Micheli Functional Scale (Function and Pain) and adverse reactions. Clinical outcomes were assessed at baseline, 1 month, 3 months and 6 months. Magnetic resonance imaging was performed at baseline and 3 months to confirm diagnosis and assess healing of lesion. Eleven participants (92%) fully returned to sport in a median time of 2.5 months (75 days; interquartile range 55 days, 85 days). All participants demonstrated marked improvements in pain and function by the end of the program. One participant (8%) had an adverse reaction during care with a significant recurrence of LBP and had not returned to sport by 6 months. Magnetic resonance imaging demonstrated improvement of the spondylolytic lesion in all but one participant. The immediate functional progression program appears a viable method for treating active spondylolysis and warrants future research.
Identifiants
pubmed: 34487947
pii: S1466-853X(21)00143-7
doi: 10.1016/j.ptsp.2021.08.009
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
140-146Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors have no conflicts of interest to report.